My Companies
Notification
Account
Log Out
Login
Board approved acquiring 60% of Meyonex Pharmaceuticals via 2.09 crore fresh shares at Rs32 each for Rs67.19 crore cash, plus in-principle fund raise via preferential/rights issue to finance deal pending definitive agreements and approvals.
Tavexia Lifecare Approves ₹67.19 Crore Meyonex Pharmaceuticals Acquisition
Tavexia Lifecare Promoter Group Sells 2.5 Lakh Shares On-Market
Tavexia Lifecare Promoter Group Sells 7 Lakh Shares On-Market
Tavexia Lifecare Promoter Group Sells 2 Lakh Shares On-Market
Tavexia Lifecare Promoter Group Sells 4 Lakh Shares On-Market